Altmeyer Anne 4

What Happened
Anne Altmeyer, a director of Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 2,412 shares on June 10, 2026. The transactions produced approximately $19,088 in proceeds at a weighted average price of $7.91 per share; individual sale prices ranged from $7.71 to $7.97. This was a sale (disposition), not a purchase.

Key Details

• Transaction date: June 10, 2026; Form 4 filed June 11, 2026 (timely).
• Transaction type/code: Sale (S).
• Shares sold: 2,412; reported proceeds: $19,088.
• Price: weighted average $7.91; range $7.71–$7.97 (sold in multiple trades).
• Post-transaction ownership: exact post-sale total not provided here; filing notes ownership includes 3,800 unvested RSUs subject to vesting (footnote).
• Notable footnotes: sale executed under a Rule 10b5-1 trading plan adopted March 11, 2026 (F1); weighted-average price and price range disclosed, and the filer can provide a breakdown of shares at each price on request (F2); 3,800 unvested RSUs are included in reported ownership (F3).

Context
The sale was made under a prearranged Rule 10b5-1 plan, which typically means the trades were automatic per a prior plan and may not reflect the insider’s contemporaneous view of the company. This is a routine director sale of modest dollar value (~$19k) and does not by itself indicate management sentiment.